Japanese group faces claim over alopecia therapy
UPDATED: A Canadian life sciences company has launched an ICDR arbitration against a Japanese cosmetics group over licensing of a cell therapy for pattern hair loss.
To read more
Subscribe to Global Arbitration Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Arbitration Review experts.